Isoxazole analogs as FXR agonists and methods of use thereof
US10450306B2 · kind B2 · utility
5Cited by
9References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2017 |
| Grant date | Oct 22, 2019 |
| Priority date | — |
| Expiry date | Oct 4, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula I, pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.